Jefferies reiterated an Underperform rating on Athenahealth (NASDAQ: ATHN), and raised the price target to $110.00 (from $105.00), ahead of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE